{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:17:15Z","timestamp":1788797835357,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.carrev.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:15:37Z","timestamp":1492820137000},"page":"431-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of ranolazine on coronary microvascular dysfunction (MICRO) study"],"prefix":"10.1016","volume":"18","author":[{"given":"Bina","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Mondragon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.carrev.2017.04.012_bb0005","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJM199306103282310","article-title":"Chest pain with normal coronary angiograms","volume":"328","author":"Cannon","year":"1993","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.carrev.2017.04.012_bb0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/jama.293.4.477","article-title":"Angina with \u201cnormal\u201d coronary arteries: a changing philosophy","volume":"293","author":"Bugiardini","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.carrev.2017.04.012_bb0015","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.carrev.2017.04.012_bb0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.carrev.2017.04.012_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCA.0000000000000119","article-title":"New insights into the pathophysiology, classification, and diagnosis of coronary microvascular dysfunction","volume":"25","author":"Ahmed","year":"2014","journal-title":"Coron Artery Dis"},{"issue":"19","key":"10.1016\/j.carrev.2017.04.012_bb0030","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.carrev.2017.04.012_bb0035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2011.03.007","article-title":"Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease","volume":"4","author":"Mehta","year":"2011","journal-title":"J Am Coll Cardiol Img"},{"issue":"25","key":"10.1016\/j.carrev.2017.04.012_bb0040","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1161\/01.CIR.0000080700.98607.D1","article-title":"Novel index for invasively assessing the coronary microcirculation","volume":"107","author":"Fearon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2017.04.012_bb0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijcard.2014.12.055","article-title":"Ranolazine: drug overview and possible role in primary microvascular angina management","volume":"181","author":"Cattaneo","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2017.04.012_bb0050","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1093\/eurheartj\/sui091","article-title":"The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction","volume":"8","author":"Belardinelli","year":"2006","journal-title":"Eur Heart J Suppl"},{"issue":"3","key":"10.1016\/j.carrev.2017.04.012_bb0055","first-page":"78","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA","volume":"44","author":"Gratsianskii","year":"2004","journal-title":"Kardiologiia"},{"issue":"12","key":"10.1016\/j.carrev.2017.04.012_bb0060","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2010.04.042","article-title":"The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease","volume":"56","author":"Stone","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2017.04.012_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1023\/A:1007705707667","article-title":"Effects of ranolazine on ischemic threshold, coronary sinus blood flow, and myocardial metabolism in coronary artery disease","volume":"11","author":"Bagger","year":"1997","journal-title":"Cardiovasc Drugs Ther"},{"issue":"Suppl. 21","key":"10.1016\/j.carrev.2017.04.012_bb0070","first-page":"A18539-A","article-title":"Intracoronary ranolazine bolus exerts a transient coronary vasodilatory action in intact porcine","volume":"122","author":"Nieminen","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.carrev.2017.04.012_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2017.04.012_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/echo.12674","article-title":"Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease","volume":"32","author":"Tagliamonte","year":"2015","journal-title":"Echocardiography"},{"issue":"17","key":"10.1016\/j.carrev.2017.04.012_bb0085","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/CIRCULATIONAHA.105.603522","article-title":"Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve","volume":"113","author":"Ng","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.carrev.2017.04.012_bb0090","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.healun.2006.03.003","article-title":"Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study","volume":"25","author":"Fearon","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl T","key":"10.1016\/j.carrev.2017.04.012_bb0095","doi-asserted-by":"crossref","first-page":"T55","DOI":"10.4244\/EIJV10STA10","article-title":"Fractional flow reserve and the index of microvascular resistance in patients with acute coronary syndromes","volume":"10","author":"Hennigan","year":"2014","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.carrev.2017.04.012_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCINTERVENTIONS.113.000462","article-title":"Coronary microvascular dysfunction after ST-segment-elevation myocardial infarction: local or global phenomenon?","volume":"6","author":"Yong","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2017.04.012_bb0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jacc.2007.08.062","article-title":"Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction","volume":"51","author":"Fearon","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838917301276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838917301276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:13:02Z","timestamp":1761559982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838917301276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1553838917301276"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2017.04.012","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of ranolazine on coronary microvascular dysfunction (MICRO) study","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}